Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Respiratory Tract Infections and Prescription Drugs in Children and in Pregnancy

This study has been completed.
Information provided by:
University of Oslo Identifier:
First received: April 22, 2010
Last updated: NA
Last verified: April 2010
History: No changes posted

The main objective is to investigate the incidence of Respiratory Tract Infections (RTIs) and antibiotic prescriptions in children and during pregnancy, the different drugs chosen by their doctors according to diagnosis, and compliance by patients. Further to investigate the possible effect of antibiotic use during pregnancy on RTIs and antibiotics and respiratory drug prescriptions in children the first two years after birth.

Specific study objectives:

  • RTIs and antibiotic prescriptions in pre-school children

    • Frequency of diagnoses and antibiotic prescriptions
    • The proportion of broad spectrum antibiotics chosen
  • Prescription patterns and treatment compliance during pregnancy

    • Incidence of diagnoses, compared with not pregnant patients
    • Choice of antibiotics in RTIs
    • Prescription collection from pharmacies
  • Antibiotics and respiratory medication in children aged 0-2 yrs

    • Compare prevalence in children of mothers with frequent RTIs/antibiotic prescriptions during pregnancy and prevalence in children of mothers with few or no consultations during pregnancy
    • Incidence of wheezing and asthma diagnoses and incidence og respiratory prescription drugs when the mother has received antibiotics in pregnancy

Respiratory Tract Diagnoses (ICPC-2)
Prescriptions of Antibiotics by General Practitioners
Prescriptions of ATC J01 and R Drugs in Participants

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Respiratory Tract Infections and Prescription Drugs in Children and in Pregnancy - a Study From Norwegian General Practice

Resource links provided by NLM:

Further study details as provided by University of Oslo:

Estimated Enrollment: 60000
Study Start Date: December 2004
Study Completion Date: April 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Children aged 0-2 yrs
Women aged 15-60 yrs


Ages Eligible for Study:   up to 60 Years   (Child, Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Contacts with general practitioner in different parts of Norway. Women aged 15-60 yrs and children 0-2 yrs are selected.

Inclusion Criteria:

  • Contact with general practitioner in the time of registration

Exclusion Criteria:

  • Men (except children aged 0-2 yrs)
  • Women in ages 2-14 and above 60 yrs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01109589

Antibiotic Centre for Primary Care, University of Oslo
Oslo, Norway, 0318
Sponsors and Collaborators
University of Oslo
  More Information

Responsible Party: Professor Morten Lindbæk, MD, PhD, Antibiotic Centre for Primary Care, University of Oslo Identifier: NCT01109589     History of Changes
Other Study ID Numbers: ASP-UIO-2010
Study First Received: April 22, 2010
Last Updated: April 22, 2010

Keywords provided by University of Oslo:

Additional relevant MeSH terms:
Respiratory Tract Infections
Respiratory Tract Diseases processed this record on May 25, 2017